Seoul Pharma Co., Ltd (KOSDAQ:018680)
South Korea
· Delayed Price · Currency is KRW 2,635.00
+115.00 (4.56%)
At close: Mar 6, 2026
Seoul Pharma Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 5, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 30,081 | 38,592 | 44,655 | 58,646 | 66,918 | 93,344 | Upgrade
|
| Market Cap Growth | -24.89% | -13.58% | -23.86% | -12.36% | -28.31% | 62.97% | Upgrade
|
| Enterprise Value | 40,264 | 44,514 | 45,715 | 75,292 | 82,364 | 102,200 | Upgrade
|
| Last Close Price | 2580.00 | 3310.00 | 3830.00 | 5030.00 | 7850.00 | 10950.00 | Upgrade
|
| PE Ratio | 16.80 | 22.72 | 12.70 | 68.58 | - | - | Upgrade
|
| PS Ratio | 0.57 | 0.72 | 0.85 | 1.17 | 1.65 | 1.79 | Upgrade
|
| PB Ratio | 0.73 | 0.96 | 1.16 | 1.66 | 3.53 | 3.24 | Upgrade
|
| P/TBV Ratio | 0.74 | 0.98 | 1.18 | 1.70 | 3.70 | 3.36 | Upgrade
|
| P/FCF Ratio | - | - | 13.24 | - | - | 17.66 | Upgrade
|
| P/OCF Ratio | - | - | 8.48 | - | - | 16.27 | Upgrade
|
| EV/Sales Ratio | 0.77 | 0.83 | 0.87 | 1.50 | 2.04 | 1.96 | Upgrade
|
| EV/EBITDA Ratio | 17.98 | 11.08 | 14.56 | 17.30 | - | 11.95 | Upgrade
|
| EV/EBIT Ratio | - | 29.14 | 37.70 | 43.30 | - | 16.72 | Upgrade
|
| EV/FCF Ratio | -8.91 | - | 13.56 | - | - | 19.34 | Upgrade
|
| Debt / Equity Ratio | 0.43 | 0.40 | 0.28 | 0.42 | 1.55 | 0.94 | Upgrade
|
| Debt / EBITDA Ratio | 7.92 | 4.01 | 3.49 | 3.43 | - | 3.17 | Upgrade
|
| Debt / FCF Ratio | - | - | 3.25 | - | - | 5.14 | Upgrade
|
| Net Debt / Equity Ratio | 0.25 | 0.21 | 0.03 | 0.09 | 0.82 | 0.42 | Upgrade
|
| Net Debt / EBITDA Ratio | 4.55 | 2.14 | 0.41 | 0.74 | -4.89 | 1.41 | Upgrade
|
| Net Debt / FCF Ratio | -2.25 | -1.64 | 0.38 | -2.45 | -5.50 | 2.29 | Upgrade
|
| Asset Turnover | 0.74 | 0.79 | 0.83 | 0.80 | 0.64 | 0.77 | Upgrade
|
| Inventory Turnover | 1.63 | 1.81 | 2.10 | 2.29 | 2.15 | 2.02 | Upgrade
|
| Quick Ratio | 1.11 | 1.20 | 0.72 | 1.20 | 0.64 | 0.99 | Upgrade
|
| Current Ratio | 2.17 | 2.28 | 1.25 | 1.87 | 0.86 | 1.41 | Upgrade
|
| Return on Equity (ROE) | 4.43% | 4.32% | 9.51% | 3.15% | -40.53% | -4.68% | Upgrade
|
| Return on Assets (ROA) | -0.38% | 1.42% | 1.21% | 1.74% | -5.61% | 5.62% | Upgrade
|
| Return on Invested Capital (ROIC) | -0.84% | 3.33% | 2.69% | 4.75% | -15.14% | 13.85% | Upgrade
|
| Return on Capital Employed (ROCE) | -0.80% | 2.70% | 2.80% | 3.60% | -17.10% | 13.10% | Upgrade
|
| Earnings Yield | 5.95% | 4.40% | 7.88% | 1.46% | -14.48% | -1.44% | Upgrade
|
| FCF Yield | -15.03% | -13.57% | 7.55% | -2.24% | -4.23% | 5.66% | Upgrade
|
| Buyback Yield / Dilution | - | - | -29.84% | -5.34% | -0.31% | -0.15% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.